Nanostring platforms advance groundbreaking studies of immune response in pig-to-human organ transplants

Seattle--(business wire)--nanostring technologies, inc. (nasdaq: nstg), a leading provider of life science tools for discovery and translational research, announced today that a team of globally renowned researchers utilized two nanostring platforms, the ncounter® analysis system and geomx® digital spatial profiler, to decode the immune response following the transplantation of genetically modified pig kidneys into humans. the groundbreaking study featured in the august issue and an accompanyin.
NSTG Ratings Summary
NSTG Quant Ranking